InvestorsObserver
×
News Home

Will Zymeworks Inc (ZYME) Stay at the Top of the Healthcare Sector?

Tuesday, November 29, 2022 02:45 PM | InvestorsObserver Analysts

Mentioned in this article

Will Zymeworks Inc (ZYME) Stay at the Top of the Healthcare Sector?

Zymeworks Inc (ZYME) is around the top of the Healthcare sector according to InvestorsObserver. ZYME received an overall rating of 39, which means that it scores higher than 39% of stocks. Additionally, Zymeworks Inc scored a 77 in the Healthcare sector, ranking it higher than 77% of stocks in that sector.

Overall Score - 39
ZYME has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on ZYME!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 39 means the stock is more attractive than 39 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Zymeworks Inc Stock Today?

Zymeworks Inc (ZYME) stock is trading at $7.82 as of 2:28 PM on Tuesday, Nov 29, a drop of -$0.02, or -0.26% from the previous closing price of $7.84. The stock has traded between $7.60 and $7.94 so far today. Volume today is less active than usual. So far 162,336 shares have traded compared to average volume of 1,430,728 shares. Click Here to get the full Stock Report for Zymeworks Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App